5072-26-4CCCCS(=N)(=O)CCC(N)C(=O)OKJQFBVYMGADDTQ-UHFFFAOYSA-NS-butyl-DL-homocysteine (S,R)-sulfoximine is a sulfoximide that is the sulfoximine derivative of an analogue of DL-methionine in which the S-methyl group is replaced by S-butyl. It has a role as a ferroptosis inducer and an EC 6.3.2.2 (glutamate--cysteine ligase) inhibitor. It contains a D-buthionine-(S,R)-sulfoximine and a L-buthionine-(S,R)-sulfoximine.
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
UsesA potent and specific inhibitor of alpha-glutamyl cysteine synthetase
UsesDL-Buthionine-sulfoximine is suitable for use to:examine whether the inhibition of glutathione by BSO enhances the apoptotic effect of estrogen on antihormone-resistant human breast cancer cellsinvestigate the effect of BSO on development of bovine embryosinhibit GSH in several studiesinvestigate the effect of GSH synthesis on oocyte maturationIt may be used to inhibit GSH and evaluate the hepatotoxicity and nephrotoxicity of natural food colorants in the absence of GSH
UsesBiological tool for depletion of glutathione.
General DescriptionDL-buthionine-SR-sulfoximine (BSO) is an amino acid analogue, which acts as an inhibitor of γ-glutamylcysteine synthetase. BSO increases the sensitivity of Trypanosoma cruzi to antiparasitic drugs, such as nifurtimox or benznidazole.
DefinitionChEBI: A sulfoximide that is the sulfoximine derivative of an analogue of DL-methionine in which the S-methyl group is replaced by S-butyl.
No reaction records under the current filter.
Loading…
5072-26-4DTXSID6044434CHEMBL1256575CHEBI:28714